AU4833500A - Antibody vaccine for autoimmune diseases - Google Patents

Antibody vaccine for autoimmune diseases

Info

Publication number
AU4833500A
AU4833500A AU48335/00A AU4833500A AU4833500A AU 4833500 A AU4833500 A AU 4833500A AU 48335/00 A AU48335/00 A AU 48335/00A AU 4833500 A AU4833500 A AU 4833500A AU 4833500 A AU4833500 A AU 4833500A
Authority
AU
Australia
Prior art keywords
autoimmune diseases
antibody vaccine
vaccine
antibody
autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48335/00A
Inventor
James Edwin Blalock
F. Shawn Galin
John Nicholas Whitaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of AU4833500A publication Critical patent/AU4833500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU48335/00A 1999-05-12 2000-05-10 Antibody vaccine for autoimmune diseases Abandoned AU4833500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13375699P 1999-05-12 1999-05-12
US60133756 1999-05-12
PCT/US2000/012727 WO2000069461A1 (en) 1999-05-12 2000-05-10 Antibody vaccine for autoimmune diseases

Publications (1)

Publication Number Publication Date
AU4833500A true AU4833500A (en) 2000-12-05

Family

ID=22460166

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48335/00A Abandoned AU4833500A (en) 1999-05-12 2000-05-10 Antibody vaccine for autoimmune diseases

Country Status (2)

Country Link
AU (1) AU4833500A (en)
WO (1) WO2000069461A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0621487B8 (en) 2006-03-23 2021-05-25 Curavac Inc peptide, therapeutic composition comprising it, use thereof, detection kit, method for manufacturing the peptide and a drug for application in myasthenia gravis

Also Published As

Publication number Publication date
WO2000069461A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
AU7912100A (en) Pharmaceutical composition comprising an antigen
HUP0200994A3 (en) Remedies for immunological diseases
AU1951201A (en) Peptide antigens
AU4935000A (en) Antibodies
AU3198200A (en) Prrsv vaccines
AU5095000A (en) Receptor interacting protein rip3
AU6045900A (en) Interaction-activated proteins
AU1608201A (en) Human zven proteins
AU6223700A (en) Gtp-binding associated proteins
AU2977500A (en) Advanced antigen presentation platform
AU5977700A (en) Vaccines
AU2452301A (en) Protein methylarginine-specific antibodies
AU6158700A (en) Vaccine
AU2001292301A1 (en) Novel drugs for liver diseases
AUPQ257199A0 (en) Vaccine antigens of moraxella
AU4833500A (en) Antibody vaccine for autoimmune diseases
AU2001245552A1 (en) Transcutaneous immunization for large particulate antigens
AU6911300A (en) Isomerase proteins
AU5811600A (en) Vaccine
AU6896300A (en) Vaccines for the treatment of autoimmune disease
AU7788600A (en) Colon-tumour-associated antigens
AU1540701A (en) Novel protein
AU4553100A (en) Tumour-associated antigen
AU6234000A (en) Methods for treating autoimmune diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase